We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$2B
AUM Growth
+$12.2M
Cap. Flow
-$123M
Cap. Flow %
-6.13%
Top 10 Hldgs %
36.44%
Holding
384
New
60
Increased
76
Reduced
187
Closed
58

Top Buys

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$39.4M
2
HPQ icon
HP
HPQ
+$34M
3
SO icon
Southern Company
SO
+$33.9M
4
CNC icon
Centene
CNC
+$33.7M
5
UGI icon
UGI
UGI
+$33M

Sector Composition

Rank Sector Weight
1 Healthcare 30.15%
2 Technology 21.65%
3 Industrials 12.91%
4 Utilities 10.27%
5 Consumer Staples 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTEX icon
76
Open Text
OTEX
$6.15B
$1.65M 0.08%
56,578
+18,426
+48% +$523K
LCI
77
DELISTED
Lannett Company, Inc.
LCI
$1.59M 0.08%
9,258
-132
-1% -$24.5K
CAT icon
78
Caterpillar
CAT
$375B
$1.56M 0.08%
17,097
+3,172
+23% +$309K
VC icon
79
Visteon
VC
$2.79B
$1.56M 0.08%
14,612
-203
-1% -$19.6K
FXN icon
80
First Trust Energy AlphaDEX Fund
FXN
$388M
$1.54M 0.08%
+73,492
New +$1.67M
IBM icon
81
IBM
IBM
$211B
$1.5M 0.07%
9,745
+1,216
+14% +$193K
ENTA icon
82
Enanta Pharmaceuticals
ENTA
$366M
$1.46M 0.07%
+28,759
New +$1.29M
CORE
83
DELISTED
Core Mark Holding Co., Inc.
CORE
$1.45M 0.07%
46,706
-650
-1% -$18.9K
MEI icon
84
Methode Electronics
MEI
$496M
$1.43M 0.07%
39,188
+11,257
+40% +$422K
SLXP
85
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$1.4M 0.07%
12,141
-240,487
-95% -$29.1M
TGT icon
86
Target
TGT
$65.6B
$1.34M 0.07%
17,642
+225
+1% +$15.2K
PG icon
87
Procter & Gamble
PG
$336B
$1.3M 0.06%
14,262
+1,797
+14% +$158K
DOX icon
88
Amdocs
DOX
$5.92B
$1.27M 0.06%
27,174
+4,184
+18% +$196K
LAZ icon
89
Lazard
LAZ
$4.13B
$1.25M 0.06%
25,044
-8,191
-25% -$406K
ACIC icon
90
American Coastal Insurance
ACIC
$515M
$1.24M 0.06%
56,697
-41,953
-43% -$781K
HAR
91
DELISTED
Harman International Industries
HAR
$1.24M 0.06%
11,627
-25,958
-69% -$2.67M
GAS
92
DELISTED
AGL Resources Inc
GAS
$1.24M 0.06%
22,650
+10,485
+86% +$554K
GILD icon
93
Gilead Sciences
GILD
$162B
$1.22M 0.06%
12,891
-1,297
-9% -$134K
IEF icon
94
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$1.21M 0.06%
+11,411
New +$1.2M
SAVE
95
DELISTED
Spirit Airlines, Inc.
SAVE
$1.2M 0.06%
15,919
+1,321
+9% +$94.5K
WAB icon
96
Wabtec
WAB
$49.1B
$1.18M 0.06%
13,601
+5,792
+74% +$488K
HPP
97
Hudson Pacific Properties
HPP
$747M
$1.18M 0.06%
+5,601
New +$1.08M
JOYY
98
JOYY Inc
JOYY
$3.71B
$1.18M 0.06%
18,845
+160
+0.9% +$11.7K
FNHC
99
DELISTED
FedNat Holding Company Common Stock
FNHC
$1.14M 0.06%
47,125
-24,148
-34% -$658K
BAX icon
100
Baxter International
BAX
$13.5B
$1.12M 0.06%
28,138
+3,404
+14% +$133K

Similar funds

Navellier & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Navellier & Associates held 384 positions worth $2B, up 0.62% from $1.99B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Navellier & Associates withdrew a net $123M in Q4 2014, closing 58 positions and reducing 187 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $71.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, Navellier & Associates opened a new position in HEALTH NET INC worth $42.8M.

  • Navellier & Associates's largest Q4 2014 buy was HEALTH NET INC: 799,779 shares worth $42.8M.
  • Navellier & Associates added most to Southern Company in Q4 2014, an estimated $33.9M increase.
  • Navellier & Associates's biggest Q4 2014 reduction was DuPont de Nemours, cutting an estimated $31.3M.
  • Navellier & Associates fully exited Thermo Fisher Scientific in Q4 2014, selling an estimated $71.9M.
  • Navellier & Associates's ten largest holdings make up 36% of its $2B portfolio in Q4 2014.
  • Navellier & Associates opened 60 new positions and closed 58 in Q4 2014.
  • Navellier & Associates's portfolio value rose 0.62% quarter-over-quarter to $2B.

Based on Navellier & Associates's 13F filing for Q4 2014, filed 2 Feb 2015.